Shenzhen Capchem Technology (300037) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
26 Oct, 2026Executive summary
Q3 revenue ¥4.602bn (+94.34% YoY) and attributable net income ¥558.6m (+111.41%); YTD revenue ¥12.065bn (+82.35%) and attributable net income ¥1.542bn (+106.19%).
Financial highlights
Net income excluding nonrecurring items was ¥573.2m in Q3 (+130.02% YoY) and ¥1.542bn YTD (+115.62%).
YTD operating profit was ¥1.823bn versus ¥885.6m in the prior-year period; total net income was ¥1.581bn versus ¥767.0m.
YTD investment income rose to ¥268.8m from ¥44.5m, mainly reflecting higher returns from joint ventures.
Key financial ratios and metrics
YTD basic EPS was ¥2.05 (+105.00% YoY) and diluted EPS was ¥1.97 (+101.02%); weighted average ROE was 13.58%.
YTD operating cash flow was ¥2.059bn (+123.18%); cash and cash equivalents increased ¥841.5m to ¥1.976bn.
Total assets reached ¥25.969bn (+31.17% vs. Dec. 31, 2025); equity attributable to shareholders was ¥11.764bn (+8.98%).
Latest events from Shenzhen Capchem Technology
- H1 2026 revenue and net profit more than doubled year-over-year, led by battery chemicals.300037
Q2 2026 - Q1 2026 saw revenue up 67.85% and net profit up 109.02% year-over-year.300037
Q1 2026 - Q3 2025 revenue up 13.6%, net profit down 7.5%, with strong cash flow and higher R&D spend.300037
Q3 2025 - H1 2025 revenue up 18.58%, net profit up 16.36%, with strong growth across all segments.300037
Q2 2025 - YTD net profit fell 12% and operating cash flow turned sharply negative.300037
Q3 2024 - Revenue up 4.35% but net profit down 19.54% as margin pressure persists; global expansion continues.300037
Q2 2024 - Q1 2025 net profit surged 39% year-over-year on strong revenue growth and improved margins.300037
Q1 2025 - Revenue up 4.85%, net profit down 6.83%, strong global expansion and R&D investment.300037
Q4 2024